Literature DB >> 27560109

Dissection of CD20 regulation in lymphoma using RNAi.

M Słabicki1,2, K S Lee1,2, A Jethwa1,2, L Sellner1,2,3, F Sacco4, T Walther1,2, J Hüllein1,2, S Dietrich1,2,3,5, B Wu1,2, D B Lipka6, C C Oakes6,7, S Mamidi8, B Pyrzyńska9, M Winiarska9, M Oleś5, M Seifert10, C Plass6, M Kirschfink8, M Boettcher11,12, J Gołąb9, W Huber5, S Fröhling1,13,14, T Zenz1,2,3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27560109     DOI： 10.1038/leu.2016.230

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.

Authors:  Y Zhang; H H Ng; H Erdjument-Bromage; P Tempst; A Bird; D Reinberg
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

2.  Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity.

Authors:  Tom van Meerten; Rozemarijn S van Rijn; Samantha Hol; Anton Hagenbeek; Saskia B Ebeling
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

3.  Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter.

Authors:  C Thévenin; B P Lucas; E J Kozlow; J H Kehrl
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

4.  Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.

Authors:  Marta Kulis; Simon Heath; Marina Bibikova; Ana C Queirós; Alba Navarro; Guillem Clot; Alejandra Martínez-Trillos; Giancarlo Castellano; Isabelle Brun-Heath; Magda Pinyol; Sergio Barberán-Soler; Panagiotis Papasaikas; Pedro Jares; Sílvia Beà; Daniel Rico; Simone Ecker; Miriam Rubio; Romina Royo; Vincent Ho; Brandy Klotzle; Lluis Hernández; Laura Conde; Mónica López-Guerra; Dolors Colomer; Neus Villamor; Marta Aymerich; María Rozman; Mónica Bayes; Marta Gut; Josep L Gelpí; Modesto Orozco; Jian-Bing Fan; Víctor Quesada; Xose S Puente; David G Pisano; Alfonso Valencia; Armando López-Guillermo; Ivo Gut; Carlos López-Otín; Elías Campo; José I Martín-Subero
Journal:  Nat Genet       Date:  2012-10-14       Impact factor: 38.330

5.  DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.

Authors:  Christopher C Oakes; Marc Seifert; Yassen Assenov; Lei Gu; Martina Przekopowitz; Amy S Ruppert; Qi Wang; Charles D Imbusch; Andrius Serva; Sandra D Koser; David Brocks; Daniel B Lipka; Olga Bogatyrova; Dieter Weichenhan; Benedikt Brors; Laura Rassenti; Thomas J Kipps; Daniel Mertens; Marc Zapatka; Peter Lichter; Hartmut Döhner; Ralf Küppers; Thorsten Zenz; Stephan Stilgenbauer; John C Byrd; Christoph Plass
Journal:  Nat Genet       Date:  2016-01-18       Impact factor: 38.330

6.  cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus.

Authors:  Christian M Hedrich; Jose C Crispin; Thomas Rauen; Christina Ioannidis; Sokratis A Apostolidis; Mindy S Lo; Vasileios C Kyttaris; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-26       Impact factor: 11.205

7.  PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes.

Authors:  A Himmelmann; A Riva; G L Wilson; B P Lucas; C Thevenin; J H Kehrl
Journal:  Blood       Date:  1997-11-15       Impact factor: 22.113

8.  Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.

Authors:  D Fitzsimmons; W Hodsdon; W Wheat; S M Maira; B Wasylyk; J Hagman
Journal:  Genes Dev       Date:  1996-09-01       Impact factor: 11.361

9.  cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells.

Authors:  Christian M Hedrich; José C Crispín; Thomas Rauen; Christina Ioannidis; Tomohiro Koga; Noe Rodriguez Rodriguez; Sokratis A Apostolidis; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

10.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962
View more
  6 in total

1.  The different predictive effects of the intensity and proportion of CD20 expression on the prognosis of B-lineage acute lymphocyte leukemia.

Authors:  Yun Tian; Xiaojiao Wang; Hao Ai; Xiaodong Lyu; Qian Wang; Xudong Wei; Yongping Song; Qingsong Yin
Journal:  EJHaem       Date:  2022-03-25

2.  L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma.

Authors:  Jiu-Yang Zhang; Pei-Pei Zhang; Wen-Ping Zhou; Jia-Yu Yu; Zhi-Hua Yao; Jun-Feng Chu; Shu-Na Yao; Cheng Wang; Waseem Lone; Qing-Xin Xia; Jie Ma; Shu-Jun Yang; Kang-Dong Liu; Zi-Gang Dong; Yong-Jun Guo; Lynette M Smith; Timothy W McKeithan; Wing C Chan; Javeed Iqbal; Yan-Yan Liu
Journal:  Clin Cancer Res       Date:  2019-03-01       Impact factor: 13.801

3.  Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma.

Authors:  Emil Aagaard Thomsen; Anne Bruun Rovsing; Mads Valdemar Anderson; Hanne Due; Jinrong Huang; Yonglun Luo; Karen Dybkaer; Jacob Giehm Mikkelsen
Journal:  Mol Oncol       Date:  2020-07-16       Impact factor: 6.603

4.  Requirement for YAP1 signaling in myxoid liposarcoma.

Authors:  Marcel Trautmann; Ya-Yun Cheng; Patrizia Jensen; Ninel Azoitei; Ines Brunner; Jennifer Hüllein; Mikolaj Slabicki; Ilka Isfort; Magdalene Cyra; Ruth Berthold; Eva Wardelmann; Sebastian Huss; Bianca Altvater; Claudia Rossig; Susanne Hafner; Thomas Simmet; Anders Ståhlberg; Pierre Åman; Thorsten Zenz; Undine Lange; Thomas Kindler; Claudia Scholl; Wolfgang Hartmann; Stefan Fröhling
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 12.137

5.  Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma.

Authors:  K Tomska; R Kurilov; K S Lee; J Hüllein; M Lukas; L Sellner; T Walther; L Wagner; M Oleś; B Brors; W Huber; T Zenz
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

Review 6.  The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy.

Authors:  Gabriela Pavlasova; Marek Mraz
Journal:  Haematologica       Date:  2020-06       Impact factor: 11.047
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.